Biotricity Inc. will demonstrate its IoT-connected medical device Bioflux, powered by AT&T, at Mobile World Congress (MWC) 2017. One of the biggest annual showcases for connected technology, MWC will be held February 27 — March 3 in Barcelona. Biotricity will showcase how IoT- Connected Healthcare devices can assist in the diagnosis of heart conditions in AT&T’s booth (#4A10).
IDC predicts the global market for IoT will nearly triple, reaching $1.7 trillion by 2020. IoT has long been considered critical to wearable innovation and is becoming more prevalent in the medical space due to its numerous applications. Telecoms are encouraging the adoption of IoT by offering value-add services to help companies, such as Biotricity, go to market with fully connected devices.
“While great progress has been made in the treatment of cardiovascular disease, it is still listed as the underlying cause of the death of more than 800,000 people in the US each year, making it a perfect application for devices that support built-in IoT capabilities,” said Waqaas Al-Siddiq, Biotricity founder and CEO. “Our medical-grade wearable is a superb example of how IoT devices can have a huge impact on healthcare. Bioflux will help diagnose patients by tracking and reporting on cardiac activity in real-time, 24/7. It will also allow physicians to monitor cardiovascular disease, especially arrhythmias, while helping to improve patient outcomes and curbing rising healthcare costs.”
Consisting of an IoT-connected device, ECG-analysis software, and comprehensive remote monitoring center access, Bioflux generates customized reports tailored to a physician’s individual patient for diagnostic purposes. Biotricity’s goal is to develop multiple solutions for chronic illnesses by designing monitoring devices paired with chronic care management tools to improve patient compliance and empower the individual to take better care of their health. The Company’s next-generation medical-grade wearables will pave the way for the adoption of preventive care measures into mainstream healthcare practices and help move from the current “reactive” model, where physicians diagnose and treat conditions and diseases after onset, to a proactive one. This is particularly true of managing heart-related illnesses because without any feedback mechanism or continuous monitoring, patients often fail to adhere to doctors’ medical directives, dietary changes, exercise regiments, and lifestyle alterations.
Announced last summer, AT&T will power Biotricity’s wearable medical devices with near real-time connectivity for data transmission. For an up close look at Bioflux while at MWC, visit AT&T’s booth (#4A10), located in the Innovation City.